Key EventTrading window closed on October 1, 2026
Key EventStrategic collaboration with Malligavad Foundation announced
Key EventEP Biocomposites AGM approves FY2025-26 financials and reappoints Rajkumar Kamat as MD
EP Biocomposites Ltd (543595)
·Next Day Close·+1.73%·₹98.18
Key EventEP Biocomposites held its 7th AGM with Chairman's speech outlining FY2025-26 results and future strategy.
ImpactEP Biocomposites is transitioning from product maker to integrated solutions provider with strong growth momentum and expanding addressable markets in critical infrastructure sectors.Sign up to read impact
EP Biocomposites Ltd (543595)
·Next Day Close·+1.73%·₹98.18
Key EventEP Biocomposites awarded 70KLD STP project by Beleza by the Beach
EP Biocomposites Ltd (543595)
·Next Day Close·-3.49%·₹96.51
Key EventPresentation prepared for upcoming Annual General Meeting
ImpactThe company's diversified sustainable infrastructure model with recurring O&M revenue and government project execution supports long-term growth potential.Sign up to read impact
EP Biocomposites Ltd (543595)
·Next Day Close·+5.56%·₹95
Key EventAGM scheduled for September 28, 2026, to approve FY2025-26 financials and reappoint Rajkumar Kamat as Managing Director.
ImpactShareholders must vote on financial approval and director reappointment, with proxy and remote voting options available.Sign up to read impact
EP Biocomposites Ltd (543595)
·Next Day Close·+5.56%·₹95
Key EventFY2025-26 revenue grew 13.6% YoY to ₹1,363.98 lakh with PAT up 41.5% to ₹145.83 lakh, driven by improved margins and project wins.
ImpactEP Biocomposites is positioned for growth through sustainable infrastructure demand, with strong margin expansion and recurring O&M revenue potential.Sign up to read impact